AAVXF
Price
$86.10
Change
+$2.75 (+3.30%)
Updated
Sep 15 closing price
Capitalization
6.54B
ACHV
Price
$2.96
Change
-$0.01 (-0.34%)
Updated
Sep 26, 12:55 PM (EDT)
Capitalization
151.78M
41 days until earnings call
Interact to see
Advertisement

AAVXF vs ACHV

Header iconAAVXF vs ACHV Comparison
Open Charts AAVXF vs ACHVBanner chart's image
Abivax SA
Price$86.10
Change+$2.75 (+3.30%)
Volume$200
Capitalization6.54B
Achieve Life Sciences
Price$2.96
Change-$0.01 (-0.34%)
Volume$100
Capitalization151.78M
AAVXF vs ACHV Comparison Chart in %
Loading...
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. ACHV commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and ACHV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (AAVXF: $86.10 vs. ACHV: $2.97)
Brand notoriety: AAVXF and ACHV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 7% vs. ACHV: 28%
Market capitalization -- AAVXF: $6.54B vs. ACHV: $151.78M
AAVXF [@Biotechnology] is valued at $6.54B. ACHV’s [@Biotechnology] market capitalization is $151.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 1 FA rating(s) are green whileACHV’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 1 green, 4 red.
  • ACHV’s FA Score: 0 green, 5 red.
According to our system of comparison, AAVXF is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 2 TA indicator(s) are bullish while ACHV’s TA Score has 4 bullish TA indicator(s).

  • AAVXF’s TA Score: 2 bullish, 4 bearish.
  • ACHV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AAVXF is a better buy in the short-term than ACHV.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while ACHV (@Biotechnology) price change was +3.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($6.54B) has a higher market cap than ACHV($152M). AAVXF YTD gains are higher at: 679.186 vs. ACHV (-15.625). ACHV has higher annual earnings (EBITDA): -49.25M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. ACHV (55.4M). ACHV has less debt than AAVXF: ACHV (9.96M) vs AAVXF (92.6M). AAVXF (0) and ACHV (0) have equivalent revenues.
AAVXFACHVAAVXF / ACHV
Capitalization6.54B152M4,303%
EBITDA-170.04M-49.25M345%
Gain YTD679.186-15.625-4,347%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M55.4M188%
Total Debt92.6M9.96M930%
FUNDAMENTALS RATINGS
AAVXF vs ACHV: Fundamental Ratings
AAVXF
ACHV
OUTLOOK RATING
1..100
2858
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
51
Fair valued
PROFIT vs RISK RATING
1..100
27100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3463
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (51) in the Biotechnology industry is in the same range as AAVXF (63) in the null industry. This means that ACHV’s stock grew similarly to AAVXF’s over the last 12 months.

AAVXF's Profit vs Risk Rating (27) in the null industry is significantly better than the same rating for ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew significantly faster than ACHV’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as ACHV (99) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's Price Growth Rating (34) in the null industry is in the same range as ACHV (63) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFACHV
RSI
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
29%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
32%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
28%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
67%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
34%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPAUF0.10N/A
+1.26%
Spanish Mountain Gold Ltd.
REPYF17.92N/A
N/A
Repsol S.A.
UNLRF0.09N/A
N/A
PT Unilever Indonesia Tbk
SWDCF3.58N/A
N/A
SWEDENCARE AB
CBUTD0.03N/A
N/A
CLEAR BLUE TECHNOLOGIES INTL INC.

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
-5.00%
CNSP - AAVXF
34%
Loosely correlated
+3.84%
ACHV - AAVXF
28%
Poorly correlated
-3.57%
RENB - AAVXF
26%
Poorly correlated
-18.54%
More

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.57%
ALT - ACHV
52%
Loosely correlated
N/A
ATNM - ACHV
39%
Loosely correlated
-1.85%
PLRX - ACHV
36%
Loosely correlated
-1.37%
NAUT - ACHV
34%
Loosely correlated
+14.16%
HOWL - ACHV
33%
Loosely correlated
-2.65%
More